drugset
drugset / Trial / NCT03973125

Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma

NCT03973125 ↗

Phase 0 Unknown 50 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

The aim of this study was to investigate the safety and effectiveness of application of intravitreal conbercept injection as the primary treatment for exudative circumscribed choroidal haemangioma.

Timeline

Start
2014-08-28
Primary completion
2020-01-01
Completion
2020-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Conbercept Protein / enzyme biologic — Intravitreal

Indications

hemangioma of choroid